These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25689487)

  • 1. High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment.
    Karchava M; Waldenström J; Parker M; Hallack R; Sharvadze L; Gatserelia L; Chkhartishvili N; Dvali N; Dzigua L; Dolmazashvili E; Norder H; Tsertsvadze T
    Hepatol Res; 2015 Dec; 45(13):1292-8. PubMed ID: 25689487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of hepatitis C virus 2k/1b intergenotypic recombinants in Georgia.
    Zakalashvili M; Zarkua J; Weizenegger M; Bartel J; Raabe M; Zangurashvili L; Kankia N; Jashiashvili N; Lomidze M; Telia T; Kerashvili V; Zhamutashvili M; Abramishvili N; Hedskog C; Chodavarapu K; Brainard DM; McHutchison JG; Mo H; Svarovskaia E; Gish RG; Rtskhiladze I; Metreveli D
    Liver Int; 2018 Mar; 38(3):451-457. PubMed ID: 28782185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of Hepatitis C Virus Genotype Recombinant Forms 2k/1b in Georgia.
    Zakalashvili M; Weizenegger M; Bartel J; Markowski M; Zarqua J; Kavsadze S; Kvatadze K; Basheleishvili G; Phirtskhalaishvili T; Dzagania T; Zangurashvili L; Kankia N; Jashiashvili N; Lomidze M; Telia T; Kerashvili V; Zhamutashvili M; Abramishvili N; Rtskhiladze I; Metreveli D
    Clin Lab; 2016 Jul; 62(7):1347-1351. PubMed ID: 28164650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of hepatitis C virus recombinant form RF1_2k/1b on treatment outcomes within the Georgian national hepatitis C elimination program.
    Karchava M; Chkhartishvili N; Sharvadze L; Abutidze A; Dvali N; Gatserelia L; Dzigua L; Bolokadze N; Dolmazashvili E; Kotorashvili A; Imnadze P; Gamkrelidze A; Tsertsvadze T
    Hepatol Res; 2018 Jan; 48(1):36-44. PubMed ID: 28258606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form.
    Schuermans W; Orlent H; Desombere I; Descheemaeker P; Van Vlierberghe H; Geerts A; Verhelst X; Reynders M; Padalko E
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27563879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential risk of misclassification HCV 2k/1b strains as HCV 2a/2c using VERSANT HCV Genotype 2.0 assay.
    De Keukeleire S; Descheemaeker P; Reynders M
    Diagn Microbiol Infect Dis; 2015 Jul; 82(3):201-2. PubMed ID: 25907374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b.
    Kurbanov F; Tanaka Y; Chub E; Maruyama I; Azlarova A; Kamitsukasa H; Ohno T; Bonetto S; Moreau I; Fanning LJ; Legrand-Abravanel F; Izopet J; Naoumov N; Shimada T; Netesov S; Mizokami M
    J Infect Dis; 2008 Nov; 198(10):1448-56. PubMed ID: 18928375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating HCV recombinant form RF1_2k/1b in blood serum of patients by real-time RT-PCR.
    Akimov IA; Timofeev DI; Mavzyutov AR; Ivanov MK
    Klin Lab Diagn; 2021 Mar; 66(2):122-128. PubMed ID: 33734647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Origin, prevalence and response to therapy of hepatitis C virus genotype 2k/1b chimeras.
    Susser S; Dietz J; Schlevogt B; Zuckerman E; Barak M; Piazzolla V; Howe A; Hinrichsen H; Passmann S; Daniel R; Cornberg M; Mangia A; Zeuzem S; Sarrazin C
    J Hepatol; 2017 Oct; 67(4):680-686. PubMed ID: 28619439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intergenotypic 2k/1b hepatitis C virus recombinants in the East Macedonia and Thrace region of Greece.
    Kassela K; Karakasiliotis I; Kokkiou E; Souvalidou F; Mimidis P; Veletza S; Panopoulou M; Koskinas J; Mimidis K; Mavromara P
    Ann Gastroenterol; 2019; 32(1):88-92. PubMed ID: 30598597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrepancy between HCV structural and non structural genes in Georgian genotype two patients.
    Tsertsvadze T; Karchava M; Sharvadze L; Gatserelia L; Dolmazashvili E
    Georgian Med News; 2014 Oct; (235):74-8. PubMed ID: 25416222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hepatitis C virus natural recombinant RF1_2k/1b strain among intravenous drug users in Uzbekistan.
    Kurbanov F; Tanaka Y; Avazova D; Khan A; Sugauchi F; Kan N; Kurbanova-Khudayberganova D; Khikmatullaeva A; Musabaev E; Mizokami M
    Hepatol Res; 2008 May; 38(5):457-64. PubMed ID: 18034826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of ineffective antiviral therapy with pegylated interferon and ribavirin in a patient with chronic hepatitis C infected with HCV genotype 2].
    Znoyko OO; Dudina KR; Kozina AN; Kalininа OV; Yushchuk ND
    Ter Arkh; 2016; 88(5):84-85. PubMed ID: 27239933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genotyping hepatitis C virus from hemodialysis patients in Central Brazil by line probe assay and sequence analysis.
    Espírito-Santo MP; Carneiro MA; Reis NR; Kozlowski AG; Teles SA; Lampe E; Yoshida CF; Martins RM
    Braz J Med Biol Res; 2007 Apr; 40(4):545-50. PubMed ID: 17401498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus genotype 1 and 2 recombinant genomes and the phylogeographic history of the 2k/1b lineage.
    Hostager R; Ragonnet-Cronin M; Murrell B; Hedskog C; Osinusi A; Susser S; Sarrazin C; Svarovskaia E; Wertheim JO
    Virus Evol; 2019 Jul; 5(2):vez041. PubMed ID: 31616569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of the 5'untranslated region (5'UTR) and non-structural 5B (NS5B) nucleotide sequences in hepatitis C virus subtyping.
    Baclig MO; Chan VF; Ramos JD; Gopez-Cervantes J; Natividad FF
    Int J Mol Epidemiol Genet; 2010 Jul; 1(3):236-44. PubMed ID: 21537395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Distribution of hepatitis C virus genotypes among patients with chronic hepatitis C infection in Akdeniz University Hospital, Antalya, Turkey: a five-year evaluation].
    Sağlik İ; Mutlu D; Öngut G; İnan D; Öğünç D; Can Sarinoğlu R; Özhak Baysan B; Gültekin M; Çolak D
    Mikrobiyol Bul; 2014 Jul; 48(3):429-37. PubMed ID: 25052109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of Sanger sequencing for hepatitis C virus genotyping with a commercial line probe assay in a tertiary hospital.
    Goletti S; Zuyten S; Goeminne L; Verhofstede C; Rodriguez-Villalobos H; Bodeus M; Stärkel P; Horsmans Y; Kabamba-Mukadi B
    BMC Infect Dis; 2019 Aug; 19(1):738. PubMed ID: 31438880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and Genotype Distribution of Hepatitis C Virus in Russia.
    Pimenov N; Kostyushev D; Komarova S; Fomicheva A; Urtikov A; Belaia O; Umbetova K; Darvina O; Tsapkova N; Chulanov V
    Pathogens; 2022 Dec; 11(12):. PubMed ID: 36558817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of treatment options for patients with hepatitis C virus recombinant form 2k/1b.
    Zakalashvili M; Zarkua J; Gish RG; Zhamutashvili M; Sartania V; Weizenegger M; Bartel J; Raabe M; Gvinjilia L; Metreveli S; Barnova M; Abramishvili N; Rtskhiladze I; Metreveli D
    Hepatol Res; 2021 Feb; 51(2):156-165. PubMed ID: 33207029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.